Pediatric hospitalization for pneurnococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong

被引：19

作者：

Ho, Pak-Leung

Chiu, Susan S.

Chow, Frankie K. H.

Mak, Gannon C.

Lau, Yu Lung

机构：

[1] Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Peoples R China

[2] Queen Mary Hosp, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China

[3] Univ Hong Kong, Ctr Infect, Hong Kong, Peoples R China

来源：

VACCINE | 2007年 / 25卷 / 39-40期

关键词：

pneumococcal disease; streptococcus pneumoniae; children;

D O I：

10.1016/j.vaccine.2007.07.039

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In a population-based study, we use ICD-9-CM codes to estimate the hospitalization rates for pneumococcal disease among young children in Hong Kong, 2000-2005 and the preventable burden using several outcome indicators. For children aged <= 2 years, the average admission rates (per 100,000 person-years) were 23.7 for invasive pneumococcal disease (IPD), 1047.5 for clinical pneumonia and 213 for radiological pneumonia. For this group of children, the disease burden potentially preventable by vaccination, per 100,000 person-years, were estimated to be 19.3 (95% CI, 16.7-21.9) for IPD, 58.5 (95% CI, 57.3-59.6) for clinical pneumonia and 40.6 (95% CI, 59-82.2) for radiological pneumonia. (C) 2007 Elsevier Ltd. All rights reserved.

引用

页码：6837 / 6841

页数：5

共 17 条

[1] Invasive pneumococcal disease in the Australian Capital Territory and Queanbeyan region: Do high infant rates reflect more disease or better detection? [J].

Andresen, DN ;

Collignon, PJ .

JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2004, 40 (04) :184-188

[2]

[Anonymous], 2000, MMWR Recomm Rep, V49, P1

[3] Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].

Black, S ;

Shinefield, H ;

Fireman, B ;

Lewis, E ;

Ray, P ;

Hansen, JR ;

Elvin, L ;

Ensor, KM ;

Hackell, J ;

Siber, G ;

Malinoski, F ;

Madore, D ;

Chang, I ;

Kohberger, R ;

Watson, W ;

Austrian, R ;

Edwards, K .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195

[4] Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia [J].

Black, SB ;

Shinefield, HR ;

Ling, S ;

Hansen, J ;

Fireman, B ;

Spring, D ;

Noyes, J ;

Lewis, E ;

Ray, P ;

Lee, J ;

Hackell, J .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (09) :810-815

[5]

Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353

[6] Influenza-related hospitalizations among children in Hong Kong [J].

Chiu, SS ;

Lau, YL ;

Chan, KH ;

Wong, WHS ;

Peiris, JSM .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (26) :2097-2103

[7] Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial [J].

Cutts, FT ;

Zaman, SMA ;

Enwere, G ;

Jaffar, S ;

Levine, OS ;

Okoko, JB ;

Oluwalana, C ;

Vaughan, A ;

Obaro, SK ;

Leach, A ;

McAdam, KP ;

Biney, E ;

Saaka, M ;

Onwuchekwa, U ;

Yallop, F ;

Pierce, NF ;

Greenwood, BM ;

Adegbola, RA .

LANCET, 2005, 365 (9465) :1139-1146

[8] Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy [J].

D'Ancona, F ;

Salmaso, S ;

Barale, A ;

Boccia, D ;

Lopalco, PL ;

Rizzo, C ;

Monaco, M ;

Massari, M ;

Demicheli, V ;

Pantosti, A .

VACCINE, 2005, 23 (19) :2494-2500

[9] Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis [J].

Grijalva, Carlos G. ;

Nuorti, J. Pekka ;

Arbogast, Patrick G. ;

Martin, Stacey W. ;

Edwards, Kathryn M. ;

Griffin, Marie R. .

LANCET, 2007, 369 (9568) :1179-1186

[10]

Guevara RE, 1999, AM J EPIDEMIOL, V149, P282, DOI 10.1093/oxfordjournals.aje.a009804

← 1 2 →